NextCure

-$0.06 (-0.74%) Today
$0.00 (0.00%) As of 8:22 PM UTC after-hours

Why Robinhood?

You can buy or sell NextCure and other stocks, options, and ETFs commission-free!

About NXTC

NextCure, Inc. Common Stock, also called NextCure, is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases.

CEO
Michael S. Richman
Employees
90
Headquarters
Beltsville, Maryland
Founded
2015

NXTC Key Statistics

Market Cap
226.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
376.27K
High Today
$8.29
Low Today
$7.95
Open Price
$8.05
Volume
224.02K
52 Week High
$37.91
52 Week Low
$7.42

NXTC Earnings

-$0.60
-$0.29
$0.02
$0.33
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.59 per share
Actual
-$0.60 per share

You May Also Like

MSACW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure